Different techniques used for the preparation of nanoparticles using natural polymers and their application

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue SUPPL. 2, 2011, Pages 45-50

  Krishna Sailaja, A ^a   Amareshwar, P ^a   Chakravarty, P ^a  

^a OSMANIA UNIVERSITY   (India)

Author keywords

Alginate nanoparticles; Deacetylation; Nanoparticles

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ALGINIC ACID; AVENIN; CELLULOSE; CHITIN; CHITOSAN; DRUG CARRIER; ETHAMBUTOL; GAMMA INTERFERON; GELATIN; GLIADIN; ISONIAZID; NANOPARTICLE; POLYELECTROLYTE; POLYMER; POLYSACCHARIDE; PYRAZINAMIDE; RIFAMPICIN; SOLVENT;

ARTICLE; BIODEGRADABILITY; CROSS LINKING; DEACETYLATION; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; EMULSION; ENCAPSULATION; GELATION; HYDROPHILICITY; MICROEMULSION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PH;

EID: 80054861520     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kreuter J. Nanoparticles. In: Colloidal Drug Delivery Systems, edited by Kreuter, J. New York: Marcel Dekker, 1994.p. 261-276.
2. Mueller, R. H. Colloidal Carriers for Controlled Drug Delivery and Targeting, Boston: CRC Press, 1991. p. 379.
3. Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 1998; 15:1326-1331.
4. Muzzarelli RAA, Baldassare V, Conti F, Gazzanelli G, Vasi V, Ferrara P, Biagini G. The biological activity of chitosan: ultrastructural study. Biomaterials. 1988;8:247-252.
5. Miyazaki S, Ishii K, Nadai T. The use of chitin and chitosan as drug carriers. Chem Pharm Bull. 1981;29:3067-3069.
6. Kurita K. Chemical modifications of chitin and chitosan. In: Muzzarelli RAA, Jeuniaux C, Gooday GW, eds. Chitin in Nature and Technology. Plenum: New York, NY. 1986:287-293.
7. Bender, von Briesen, Kreuter J, Duncan I. B, and Rubsamen-Waigmann H. Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human oncocytes/macrophages in vitro. Antimicrob. Agents Chemothe;1996;.40: 1467-1471.
8. Luessen H. L, de Leeuw B.J, Langemeyer M.W, de Boer A.B, Verhoef J.C, and Junginger H.E. Mucoadhesive polymers in peroral peptide drug delivery. VI.Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 1996; 13: 1668-1672.
9. Fernandez-Urrusuno,. Calvo R.P, Remunan-Lopez C, Vila-Jato J.L, and Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res. 1999; 16: 1576-1581.
10. Dyer, A. M, Hinchcliffe M, Watts P, Castile J, Jabbal-Gil I, Nankervis R, Smith A, and Illum L. Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles. Pharm. Res. 2002;19:998-1008.
11. Erbacher, Zou P.S, Steffan A.M, and Remy J.S. Chitosan-based vector/ DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm.Res. 1998; 15: 1332-1339.
12. Guang Liu, W. and K. De Yao. Chitosan and its derivatives a promising non-viral vector gene transfection. J. Control. Release 2002; Vol. 83, pp. 1-11.
13. Qurrat-ul Ain, Sharma S, Khuller GK, Garg SK. Alginate based oral drug delivery system for tuberculosis: pharmacokinetics and therapeutic effects. J Antimicrob Chemother 2003; 51: 931-8.
14. Yi YM, Yang TY, Pan WM. Preparation and distribution of 5- fluorouracil 125I sodium alginate-bovine serum albumin nanoparticles. World J Gastroenterol 1999; 5: 57-60.
15. Zhang Chuang Nian, Wang Wei, Wang Chun Hong. Cytotoxicity of liver targeted drug-loaded alginate Nanoparticles. Sci China Ser BChem Sep. 2009; 52(9); 1382-1387.
16. Coester, C.J., Langer, K., Von Briesen., gelatin nanoparticles by two step desolvation- A new preparation method,surface modifications and cell uptake. J.microencapsule. 2000,17(2); 187-193.
17. Conrad coester, Klaus Zwiorek., Gelatin nanoparticles as a new and simple gene Delivery system. J Pharm.pharmaceut Sci 2004;7(4):22-28.
18. Ze Lu, Teng-Kuang Yeh, Max Tsai, Paclitaxel-Loaded Gelatin Nanoparticles for Intravesical Bladder Cancer Therapy Clinical Cancer Research 2004;Vol. 10 November 15, 7677-7684.
19. Roth BJ. Preliminary experience with paclitaxel in advanced bladder cancer. Semin Oncol 1995;22:1-5.
20. Au JL, Kalns J, Gan Y, Wientjes MG. Pharmacologic effects of paclitaxel in human bladder tumors. Cancer Chemother Pharmacol 1997;41:69-74.
21. Merodio M., Arnedo A, Renedo M.J., Irache J.M, Ganciclovirloaded albumin nanoparticles:characterization and in vitro release properties, European J of Pharmceutical Sciences, (2001); Vol.12(3), 251.
22. Saikat Das, Rinti Banerjee and Jayesh Bellare. Aspirin Loaded Albumin Nanoparticles by Coacervation: Implications in Drug Delivery Trends Biomater. Artif. Organs, 2005; Vol 18 (2): January 203-212.
23. Sigura S, Gamazo C; Interferon-g loaded albumin nanoparticles:invitro and invivo activity against Brucella abortus. 2007 January.
24. Ezpeleta I, Irache JM, Stainmesse S, Chabenat C, Gueguen J, Popineau Y, Orecchioni AM Gliadin nanoparticles for the controlled release of all-trans-retinoic acid. Int. J. Pharm. (1996); 131: 191-200.
25. Ezpeleta I, Irache JM, Stainmesse S, Chabenat C, Popineau Y, Orecchionic AM Preparation of Ulex europaeus lectin-gliadin nanoparticles conjugates and their interaction with gastrointestinal mucus. Int. J. Pharm. (1999);191: 25-32.